Short‐ and Long‐Term Cure Rates of Short‐Duration Trimethoprim‐Sulfamethoxazole Treatment in Female Dogs with Uncomplicated Bacterial Cystitis

Background Long‐duration beta‐lactam antibiotics are used for empirical treatment in female dogs with uncomplicated bacterial cystitis. However, women with bacterial cystitis are treated with short‐duration potentiated sulfonamides because longer courses of beta‐lactams result in lower cure and higher recurrence rates. Hypothesis/Objectives Short‐duration potentiated sulfonamide treatment is more efficacious than long‐duration beta‐lactam treatment in achieving clinical and microbiological cures in female dogs with uncomplicated bacterial cystitis. Animals Thirty‐eight client‐owned female dogs. Methods Randomized, double‐blinded, placebo‐controlled clinical trial. Dogs were treated with TMP ‐ SMX (15 mg/kg PO q12h for 3 days followed by a placebo capsule PO q12h for 7 days; Group SDS ; n = 20) or cephalexin (20 mg/kg PO q12h for 10 days; Group LDBL ; n = 18). Dogs were monitored for clinical and microbiological cure during treatment and at short‐ and long‐term follow‐up. Results No statistically significant differences were found between treatment groups in clinical cure rates after 3 days of treatment (89% SDS , 94% LDBL ; P  = 1.00) and 4 days (85% SDS , 72% LDBL ; P  = .44) or >30 days (50% SDS , 65% LDBL ; P  = .50) after conclusion of treatment or in microbiological cure rates 4 days (59% SDS , 36% LDBL ; P  = .44) or >30 days (44% SDS , 20% LDBL ; P  = .40) after conclusion of treatment. Conclusions and Clinical Importance We did not identify a difference in cure rates between short‐duration sulfonamide and long‐duration beta‐lactam treatments in female dogs with uncomplicated cystitis. Long‐term cure rates in both treatment groups were low. In some female dogs, “uncomplicated” bacterial cystitis may be more complicated than previously recognized.